These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 14749143

  • 1. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
    Setter SM, Iltz JL, Thams J, Campbell RK.
    Clin Ther; 2003 Dec; 25(12):2991-3026. PubMed ID: 14749143
    [Abstract] [Full Text] [Related]

  • 2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004 Dec; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Dec; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 4. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
    Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM, Raskin P.
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An overview of metformin in the treatment of type 2 diabetes mellitus.
    Davidson MB, Peters AL.
    Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [Abstract] [Full Text] [Related]

  • 11. A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol.
    Gupta M, Braga MB, Verma S.
    Can J Cardiol; 2008 Oct; 24(10):e65-9. PubMed ID: 18841263
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes.
    Cox SL.
    Drugs Today (Barc); 2004 Jul; 40(7):633-43. PubMed ID: 15510236
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD, Campbell LK, Campbell RK.
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [Abstract] [Full Text] [Related]

  • 17. Thiazolidinedione derivatives in type 2 diabetes mellitus.
    Tack CJ, Smits P.
    Neth J Med; 2006 Jun; 64(6):166-74. PubMed ID: 16788214
    [Abstract] [Full Text] [Related]

  • 18. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M, Lam S.
    Cardiol Rev; 2007 Jun; 15(5):264-71. PubMed ID: 17700385
    [Abstract] [Full Text] [Related]

  • 19. Rosiglitazone/Metformin.
    Wellington K.
    Drugs; 2005 Jun; 65(11):1581-92; discussion 1593-4. PubMed ID: 16033298
    [Abstract] [Full Text] [Related]

  • 20. How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
    Bell DS, Ovalle F.
    Endocr Pract; 2000 Jun; 6(4):293-5. PubMed ID: 11242605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.